InMed Pharmaceuticals Inc (INM) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $0.88
• Market Cap: $2.60M
• EPS: $-6.09
• 52-Week High: $5.50
• 52-Week Low: $0.85

Market Sentiment

InMed Pharmaceuticals Inc currently has a Neutral sentiment score of -0.08.

About InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm headquartered in Vancouver, Canada, dedicated to the discovery and development of innovative cannabinoid-based therapies for a range of medical conditions. Utilizing its proprietary biosynthesis technology, InMed is committed to producing pharmaceutical-grade cannabinoids aimed at addressing significant unmet medical needs. With a well-defined pipeline of drug candidates advancing through clinical trials, the company is str...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for InMed Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INM pay dividends?

InMed Pharmaceuticals Inc (INM) does not currently pay a regular dividend.

What is INM's market cap?

InMed Pharmaceuticals Inc (INM) has a market capitalization of $2.60M with a current stock price of $0.88.